SML3538
CKJB71
≥98% (HPLC)
别名:
5-(4-Methylpiperazine-1-carbonyl)-7,10-dioxa-13,17,18,21-tetraazatetracyclo[12.5.2.1²,⁶.0¹⁷,²⁰]docosa-1(20),2,4,6(22),14(21),15,18-heptaene, CK156 inactive control, CK156 negative control
登录 查看组织和合同定价。
选择规格
变更视图
关于此项目
经验公式（希尔记法）:
C22H26N6O3
分子量:
422.48
UNSPSC Code:
12352200
NACRES:
NA.77
Assay:
≥98% (HPLC)
Form:
powder
Quality Segment
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
2-8°C
SMILES string
O=C(N1CCN(C)CC1)C(C=C2)=C(OCCOCCNC3=N4)C=C2C5=C4N(C=C3)N=C5
InChI
1S/C22H26N6O3/c1-26-7-9-27(10-8-26)22(29)17-3-2-16-14-19(17)31-13-12-30-11-5-23-20-4-6-28-21(25-20)18(16)15-24-28/h2-4,6,14-15H,5,7-13H2,1H3,(H,23,25)
InChI key
DDXOMWWURGFLKK-UHFFFAOYSA-N
Biochem/physiol Actions
CKJB71 is an inactive analog of and negative control (IC50 = 20 μM and >45 μM using cell lysate or by inact cell NanoBRET) for the potent and selective DRAK1 (STK17A) inhibitor CK156.
Inactive analog of and negative control for the potent and selective DRAK1 (STK17A) inhibitor CK156.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable